This is a demo store. No orders will be fulfilled.

Healthcare

Healthcare, the world's largest industry, is transforming faster than ever. The focus on outcomes based medicine and optimal health management of populations will result in major seismic shifts. Modernization and reform measures are being employed globally by public and private sector organizations to meet the growing need for healthcare. New technologies are being created, offering enormous promise to improve care delivery.

Our Transformational Health practice serves all key industry stakeholders through partnership models that provide access to high-quality content and our global team of industry experts. The practice includes Visionary Health, Life Sciences, Advanced Medical Technologies and Connected Health, focusing on evolving healthcare technologies and covering the entire industry spectrum

  1. 23 Feb 2021  |  North America  |  Mega Trends

    AI-Based Image Analysis Tools and Cloud-Based Deployment to Expand the Global Digital Pathology Market

    Increased Demand for Remote Pathology Services and Centralization of Digital Pathology Workflow in Hospital Networks to Spark New Growth Opportunities

    The Transformational Health team at Frost & Sullivan provides critical insights into the global digital pathology market, highlighting key growth opportunities, market revenue forecast, and business models that will play an essential role in its growth. The study segments the market by product (hardware, software, and storage solutions) and region ...

    $4,950.00
  2. 19 Feb 2021  |  North America  |  Mega Trends

    Regulatory and Infrastructure Reforms in India and China Catalyzing the Asian Specialty Generics Market

    High Unmet Needs in Niche Oncology Indications will Drive Future Growth Potential

    Frost & Sullivans Transformational Health team provides critical insights into the Asian specialty generics market with this research service, highlighting growth opportunities, selected countries biopharmaceutical environment, and significant R&D, regulatory, and infrastructure reforms influencing its growth. The report examines similarities and c...

    $2,450.00
  3. 16 Feb 2021  |  North America  |  Mega Trends

    Smartphone-based Saliva Testing and Self-monitoring of Blood Glucose Driving the Digital POCT Market

    Mobility Ecosystem Holds Bold Promise to Expand Patients’ Access to Care

    Smartphone-based devices and associated tools are becoming the ideal next-generation point-of-care testing (POCT) solutions for in vitro diagnostics. The global COVID-19 pandemic has led to frugal innovations in POCT. The World Health Organization (WHO) has endorsed POCT as the topmost research priority in response to the COVID-19 outbreak. Digital...

    $2,450.00
  4. 05 Feb 2021  |  North America  |  Mega Trends

    Shifting Spotlight from Product- to Value-based Outcomes Intensifies Growth in the US Real-world Evidence IT Solutions Market

    Early-stage R&D and Commercial Applications Fuel the Growth Pipeline

    The US healthcare industrys transition to a patient-centric model is moving rapidly with focus on outcomes and value; however, drug prices have increased and pharmaceutical research and development (R&D) productivity is at its lowest. The healthcare industry and IT solutions providers are finding real-world evidence (RWE) as a potential solution to...

    $4,950.00
  5. 03 Feb 2021  |  North America  |  Mega Trends

    Companion Diagnostics (CDx) is Revolutionizing the Global Clinical Next-generation Sequencing (NGS) Market

    Next-generation Blockchain-Powered Genomic Data Marketplaces are Creating New Growth Opportunities

    2020 will be remembered for the COVID-19 pandemic, masks, social distancing protocol, alternate care sites, Moderna, Pfizer, BioNTech, AstraZeneca, RT-PCR, and serology testing (or all the above). However, in the midst of our response to the global pandemic, remarkable advancements were made in another great frontier in medicine that remains unconq...

    $4,950.00
  6. 21 Dec 2016  |  Africa  |  Market Research

    African Pharmaceuticals Market, Forecast to 2020

    Assessing Market Potential with a Focus on Kenya and Nigeria

    The pharmaceuticals market in Africa is expected to reach a business opportunity of $45 billion in 2020, propelled by a convergence of changing economic profiles, rapid urbanisation, increased healthcare spending and investment, and increasing incidence of chronic lifestyle diseases. The tropical climate of Africa makes the continent the largest re...

    $4,950.00
  7. 19 Dec 2016  |  Global  |  Customer Research

    Global Laboratory Products Purchasing Trends, 2016–2017

    An End-user Perspective on the Purchasing Process, Product Budgets, and Top Companies for Laboratory Products

    Readers of Lab Manager Magazine were invited to participate in an online survey in July 2016. To qualify for survey participation, readers had to play a role in their laboratory’s purchasing process, be familiar with their laboratory’s product budgets, and represent a laboratory that either uses or plans to use products in 1 or more of the 7 sp...

    $6,000.00
  8. 14 Nov 2016  |  Asia Pacific  |  Market Research

    Analysis of the Indonesian Clinical Laboratories Market

    Increase in Test Volumes Due to Universal Health Coverage will Boost Market Growth Across All Segments

    Given the ever-increasing cost of care, healthcare delivery is moving towards decentralisation. Service delivery from health settings such as mobile clinics, rapid retail clinics, and home settings demands the use of new-age clinic laboratory diagnostics. Effective delivery of healthcare services has created a business and technology convergence be...

    $1,500.00
  9. 11 Nov 2016  |  North America  |  Market Research

    Global Orphan Drug Market

    High Pricing and Undefined Reimbursement Policies will Limit the Sales of Orphan Drugs

    The treatment of rare diseases requires the use of specialized drugs. Patient populations for rare diseases are most often quite small, consequently the products treating them earn the designation orphan drugs. These drugs must undergo the research, development, and clinical trials that all drugs do, yet the investment into the development is great...

    $6,000.00
  10. 11 Nov 2016  |  Asia Pacific  |  Market Research

    Analysis of the Australian Clinical Laboratory Market

    Evolving Business Model—Technological Advances will Drive the Market

    Given the ever increasing cost of care, healthcare delivery is moving towards decentralisation. Service delivery from healthcare settings such as mobile clinics, rapid retail clinics, and home settings demands the use of new-age clinical laboratory diagnostics. The effective delivery of healthcare services has created a business and technology conv...

    $1,500.00